Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Dermatology
|
March 29, 2025
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study
Hirohiko Sueki, Seiko Sugiyama, Yumi Aoyama, et al.
Journal of Dermatological Science
|
October 13, 2020
The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018
Yuma Sunaga, Michiko Kurosawa, Hirotaka Ochiai, et al.
Cureus
|
April 8, 2025
Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey
Yuto Yamamura, Chisa Nakashima, Nana Kagawa, et al.
Journal of Dermatological Science
|
July 26, 2022
Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients
Yuma Sunaga, Natsumi Hama, Hirotaka Ochiai, et al.
Oncoimmunology
|
February 16, 2017
Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma
Yuki Honda, Atsushi Otsuka, Sachiko Ono, et al.
Endocrine Journal
|
June 5, 2024
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
Katsunori Manaka, Junichiro Sato, Yusuke Hikima, et al.
American Journal of Ophthalmology
|
May 25, 2024
Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan
Miho Kojima, Hiroki Mieno, Mayumi Ueta, et al.
The Lancet. Haematology
|
February 6, 2026
Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Rudolf Stadler, Pietro Quaglino, F J Sherida H Woei-A-Jin, et al.
Nature
|
October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
Thierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
The British Journal of Dermatology
|
August 14, 2024
Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment
Natsumi Hama, Shigeki Aoki, Chun-Bing Chen, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Dermatology
|
March 29, 2025
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study
Hirohiko Sueki, Seiko Sugiyama, Yumi Aoyama, et al.
Journal of Dermatological Science
|
October 13, 2020
The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018
Yuma Sunaga, Michiko Kurosawa, Hirotaka Ochiai, et al.
Cureus
|
April 8, 2025
Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey
Yuto Yamamura, Chisa Nakashima, Nana Kagawa, et al.
Journal of Dermatological Science
|
July 26, 2022
Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients
Yuma Sunaga, Natsumi Hama, Hirotaka Ochiai, et al.
Oncoimmunology
|
February 16, 2017
Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma
Yuki Honda, Atsushi Otsuka, Sachiko Ono, et al.
Endocrine Journal
|
June 5, 2024
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
Katsunori Manaka, Junichiro Sato, Yusuke Hikima, et al.
American Journal of Ophthalmology
|
May 25, 2024
Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan
Miho Kojima, Hiroki Mieno, Mayumi Ueta, et al.
The Lancet. Haematology
|
February 6, 2026
Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Rudolf Stadler, Pietro Quaglino, F J Sherida H Woei-A-Jin, et al.
Nature
|
October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
Thierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
The British Journal of Dermatology
|
August 14, 2024
Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment
Natsumi Hama, Shigeki Aoki, Chun-Bing Chen, et al.
Page
of 14